Ludwig Enterprises (LUDG) Net Income towards Common Stockholders (2022 - 2026)
Ludwig Enterprises (LUDG) posted Net Income towards Common Stockholders of $218847.0 for Q1 2026, up 120.31% on a QoQ basis from -$1.1 million in Q4 2025, and up 140.46% year-over-year from $91013.1 in Q1 2025.
Ludwig Enterprises (LUDG) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
Ludwig Enterprises' Net Income towards Common Stockholders history runs 5 years deep, the most recent figure standing at $218847.0 for Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 140.46% year-over-year to $218847.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 35.98% YoY) and the FY2025 annual result came in at -$2.2 million, down 6525.98% from the prior year.
- Net Income towards Common Stockholders was $218847.0 for Q1 2026 at Ludwig Enterprises, up from -$1.1 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $245833.0 in Q4 2024 and bottomed at -$1.1 million in Q4 2025.
- A 5-year average of -$374817.3 and a median of -$456322.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders surged 166.14% — and 2025, when it sank 1562.6%.
- Ludwig Enterprises' Net Income towards Common Stockholders stood at -$681105.0 in 2022, then jumped by 45.43% to -$371701.0 in 2023, then jumped by 166.14% to $245833.0 in 2024, then slumped by 538.22% to -$1.1 million in 2025, then surged by 120.31% to $218847.0 in 2026.
- Business Quant data shows LUDG's Net Income towards Common Stockholders at $218847.0 in Q1 2026, -$1.1 million in Q4 2025, and $31252.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Ludwig Enterprises | 3.27 Mn | 3.27 Mn | - | 218,847.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218,847.00 |
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | 31,252.00 |
| Jun 30, 2025 | -649,444.00 |
| Mar 31, 2025 | -540,943.00 |
| Dec 31, 2024 | 245,833.00 |
| Sep 30, 2024 | -749,129.00 |
| Jun 30, 2024 | -41,681.00 |
| Mar 31, 2024 | -32,536.00 |
| Dec 31, 2023 | -371,701.00 |
| Sep 30, 2023 | -195,570.00 |
| Jun 30, 2023 | -583,447.00 |
| Mar 31, 2023 | -820,520.00 |
| Dec 31, 2022 | -681,105.00 |